{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:00:21Z","timestamp":1791489621668,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":244,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101424","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:51:17Z","timestamp":1790337077000},"page":"101424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Gene expression of LncRNA CASC9, miR-590-3p, and NF-\u03baB p65, and immunohistochemical expression of BAX and BCL-2 in breast cancer tissues"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7407-1608","authenticated-orcid":false,"given":"Samia","family":"Hussein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Zahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr A.","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia M.A.","family":"El-said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham","family":"Sameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Barakat","family":"Waley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa H.S.","family":"Hussien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem","family":"Amgd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihab","family":"Matar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Mohammed","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba Alhussein","family":"Abo-alella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1471-1850","authenticated-orcid":false,"given":"Ahmed","family":"Algazeery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101424_bib0001","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.1002\/jcb.28211","article-title":"MicroRNA-590-3P suppresses cell survival and triggers breast cancer cell apoptosis via targeting sirtuin-1 and deacetylation of p53","volume":"120","author":"Abdolvahabi","year":"2019","journal-title":"J. Cell Biochem."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101424_bib0017","doi-asserted-by":"crossref","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","article-title":"Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study","volume":"8","author":"Heer","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ctarc.2026.101424_bib0004","first-page":"5548","article-title":"Custom fluorescence imaging system exploiting hyperspectral camera to characterize and diagnose RNA breast cancer","volume":"2","author":"Aref","year":"2021","journal-title":"Biointerface Res. Appl. Chem."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101424_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.102198","article-title":"Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: a systematic review and meta-analysis","volume":"8","author":"Rizzo","year":"2023","journal-title":"ESMo Open."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101424_bib0049","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/ijc.32584","article-title":"Effect of screening mammography on breast cancer mortality: quasi-experimental evidence from rollout of the Dutch population-based program with 17-year follow-up of a cohort","volume":"146","author":"Van Ourti","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101424_bib0013","first-page":"525","article-title":"Diagnostic and prognostic biomarkers of luminal breast cancer: where are we now?","volume":"Volume 15","author":"H\u00f6ller","year":"2023","journal-title":"Breast. Cancer (Dove Med. Press)"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101424_bib0034","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/jnci\/djaa201","article-title":"Assessment of Ki67 in breast cancer: updated recommendations from the International Ki67 in Breast Cancer Working Group","volume":"113","author":"Nielsen","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ctarc.2026.101424_bib0009","series-title":"InSeminars in Oncology Nursing","article-title":"From serum markers to liquid biopsy: precision monitoring in breast, ovarian, pancreatic, and prostate cancers","author":"Connors","year":"2026"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101424_bib0007","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101424_bib0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5858\/arpa.2022-0070-RA","article-title":"Molecular classification of breast cancer: relevance and challenges","volume":"147","author":"Zhang","year":"2023","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101424_bib0051","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.3390\/ijms22063137","article-title":"Decoding the roles of long noncoding RNAs in hepatocellular carcinoma","volume":"22","author":"Wong","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101424_bib0046","first-page":"1665","article-title":"lncRNA CASC9 positively regulates CHK1 to promote breast cancer cell proliferation and survival through sponging the miR-195\/497 cluster","volume":"54","author":"Shao","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101424_bib0012","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12253-019-00703-3","article-title":"LncRNA CASC9 suppressed the apoptosis of gastric cancer cells through regulating BMI1","volume":"26","author":"Fang","year":"2020","journal-title":"Pathol. Oncol. Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101424_bib0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13046-019-1263-3","article-title":"LncRNA CASC9 interacts with CPSF3 to regulate TGF-\u03b2 signaling in colorectal cancer","volume":"38","author":"Luo","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"15","key":"10.1016\/j.ctarc.2026.101424_bib0043","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1158\/0008-5472.CAN-17-3014","article-title":"miR-590-3p promotes ovarian cancer growth and metastasis via a novel FOXA2\u2013versican pathway","volume":"78","author":"Salem","year":"2018","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101424_bib0054","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3892\/ol.2021.12805","article-title":"Long non-coding RNA CASC9\/microRNA-590-3p axis participates in lutein-mediated suppression of breast cancer cell proliferation","volume":"22","author":"Zhang","year":"2021","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101424_bib0016","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03bab in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101424_bib0047","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3109\/02841860902988688","article-title":"The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer","volume":"48","author":"Sj\u00f6str\u00f6m-mattson","year":"2009","journal-title":"Acta Oncol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101424_bib0022","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.31557\/APJCP.2019.20.10.3113","article-title":"Health-related quality of life among Egyptian female breast cancer patients at the National Cancer Institute, Cairo University","volume":"20","author":"Khater","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101424_bib0024","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s12282-020-01081-4","article-title":"Annual report of the Japanese breast cancer society registry for 2016","volume":"27","author":"Kubo","year":"2020","journal-title":"Breast. Cancer"},{"key":"10.1016\/j.ctarc.2026.101424_bib0005","article-title":"Clinicopathologic features of breast cancer in Egypt-contemporary profile and future needs: a systematic review and meta-analysis","volume":"9","author":"Azim","year":"2023","journal-title":"JCo. Glob. Oncol."},{"key":"10.1016\/j.ctarc.2026.101424_bib0003","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amsu.2019.11.021","article-title":"Molecular classification of breast cancer: a retrospective cohort study","volume":"49","author":"Al-Thoubaity","year":"2020","journal-title":"Ann. Med. Surg. (L.)"},{"key":"10.1016\/j.ctarc.2026.101424_bib0045","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s43055-026-01761-9","article-title":"Can MRI predict lymphovascular invasion in breast cancer? A radiological-pathological observational insights","volume":"57","author":"Settein","year":"2026","journal-title":"Egypt. J. Radiol. Nucl. Med."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101424_bib0038","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3126\/jpn.v6i11.15674","article-title":"Histopathological evaluation of carcinoma of breast","volume":"6","author":"Pathak","year":"2016","journal-title":"J. Pathol. Nepal"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101424_bib0025","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3390\/biomedicines11030968","article-title":"Updates on lymphovascular invasion in breast cancer","volume":"11","author":"Kuhn","year":"2023","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101424_bib0023","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.clbc.2016.02.005","article-title":"Mammography, US, and MRI for preoperative prediction of extensive intraductal component of invasive breast cancer: interobserver variability and performances","volume":"16","author":"Kim","year":"2016","journal-title":"Clin. Breast. Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101424_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4048\/jbc.2020.23.e24","article-title":"Breast cancer statistics in Korea in 2017: data from a Breast cancer registry","volume":"23","author":"Kang","year":"2020","journal-title":"J. Breast. Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101424_bib0018","first-page":"2801","article-title":"Long noncoding RNA cancer susceptibility candidate 9 promotes doxorubicin-resistant breast cancer by binding to enhancer of zeste homolog 2","volume":"42","author":"Jiang","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101424_bib0011","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/kjm2.12573","article-title":"LncRNA CASC9 activated by STAT3 promotes the invasion of breast cancer and the formation of lymphatic vessels by enhancing H3K27ac-activated SOX4","volume":"38","author":"Fan","year":"2022","journal-title":"Kaohsiung. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101424_bib0052","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1074\/jbc.M117.814368","article-title":"Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth","volume":"293","author":"Woodcock","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ctarc.2026.101424_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.102924","article-title":"Post-progression treatment options after CDK4\/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer","volume":"135","author":"Sahin","year":"2025","journal-title":"Cancer Treat. Rev."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101424_bib0053","first-page":"965","article-title":"MicroRNA-590-3p inhibits invasion and metastasis in triple-negative breast cancer by targeting Slug","volume":"10","author":"Yan","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101424_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169622","article-title":"NF-kappaB is involved in the regulation of EMT genes in breast cancer cells","volume":"12","author":"Pires","year":"2017","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101424_bib0002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000527828","article-title":"Nuclear factor-\u03bab clinical significance in breast cancer: an immunohistochemical study","volume":"32","author":"Al-Mutairi","year":"2023","journal-title":"Med. Princ. Pr."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101424_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e32857","article-title":"Abnormal activation of genomic LINE1 elements caused by DNA demethylation contributes to lncRNA CASC9 overexpression in esophageal squamous cell carcinoma","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101424_bib0035","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1002\/cam4.770","article-title":"The long noncoding RNA CASC9 regulates migration and invasion in esophageal cancer","volume":"5","author":"Pan","year":"2016","journal-title":"Cancer Med."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101424_bib0029","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1111\/jcmm.13932","article-title":"Long noncoding RNA CASC9\/miR-519d\/STAT3 positive feedback loop facilitate glioma tumourigenesis","volume":"22","author":"Liu","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101424_bib0033","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1096\/fj.09-138305","article-title":"BCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells","volume":"24","author":"Nehra","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.ctarc.2026.101424_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/9905776","article-title":"NF-\u03bab-activated lncRNACASC9 promotes bladder cancer progression by regulating the TK1 expression","volume":"2022","author":"Longjun","year":"2022","journal-title":"J. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101424_bib0036","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/annonc\/mdm538","article-title":"Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes","volume":"19","author":"Park","year":"2008","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101424_bib0032","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10549-019-05357-y","article-title":"The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society registry","volume":"177","author":"Nam","year":"2019","journal-title":"Breast. Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101424_bib0031","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ncrna.2020.11.004","article-title":"Long non-coding RNAs in breast cancer metastasis","volume":"5","author":"Mondal","year":"2020","journal-title":"Noncoding. RNa Res."},{"key":"10.1016\/j.ctarc.2026.101424_bib0006","doi-asserted-by":"crossref","first-page":"33002","DOI":"10.18632\/oncotarget.16031","article-title":"The relationship between members of the canonical NF-\u03bab pathway, components of tumour microenvironment and survival in patients with invasive ductal breast cancer","volume":"8","author":"Bennett","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101424_bib0050","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4149\/317_151013N525","article-title":"NF-\u03bab\/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival","volume":"63","author":"Voboril","year":"2016","journal-title":"Neoplasma"},{"issue":"21","key":"10.1016\/j.ctarc.2026.101424_bib0010","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.7150\/jca.34302","article-title":"Differential impact of classical and non-canonical NF-\u03bab pathway-related gene expression on the survival of breast cancer patients","volume":"10","author":"Espinoza-S\u00e1nchez","year":"2019","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101424_bib0021","doi-asserted-by":"crossref","first-page":"56","DOI":"10.18632\/aging.101359","article-title":"NKILA inhibits NF-\u03bab signaling and suppresses tumor metastasis","volume":"10","author":"Ke","year":"2018","journal-title":"Aging"},{"key":"10.1016\/j.ctarc.2026.101424_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23102","article-title":"The RAS-PI3K-AKT-NF-\u03bab pathway transcriptionally regulates the expression of BCL2 family and IAP family genes and inhibits apoptosis in fibrous epulis","volume":"34","author":"Jiang","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101424_bib0026","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12935-021-01752-y","article-title":"TIMELESS inhibits breast cancer cell invasion and metastasis by down-regulating the expression of MMP9","volume":"21","author":"Li","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101424_bib0027","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jamcollsurg.2003.08.008","article-title":"Prognostic significance of p53, bcl-2, and bax expression in early breast cancer","volume":"198","author":"Linjawi","year":"2004","journal-title":"J. Am. Coll. Surg."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101424_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.sjbs.2023.103916","article-title":"Clinicopathological significance and expression pattern of Bcl2 in breast cancer: a comprehensive in silico and in vitro study","volume":"31","author":"Sofi","year":"2024","journal-title":"Saudi. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101424_bib0037","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/1673-5374.286946","article-title":"Oxidative stress battles neuronal bcl-xL in a fight to the death","volume":"16","author":"Park","year":"2021","journal-title":"Neural. Regen. Res."},{"key":"10.1016\/j.ctarc.2026.101424_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.985363","article-title":"The role of BCL-2 family proteins in regulating apoptosis and cancer therapy","volume":"12","author":"Qian","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101424_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123889","article-title":"Recent trends and advances in novel formulations as an armament in Bcl-2\/Bax targeted breast cancer","volume":"653","author":"Samia","year":"2024","journal-title":"Int. J. Pharm."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:38:30Z","timestamp":1791488310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226003345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":53,"alternative-id":["S2468294226003345"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101424","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene expression of LncRNA CASC9, miR-590-3p, and NF-\u03baB p65, and immunohistochemical expression of BAX and BCL-2 in breast cancer tissues","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101424"}}